AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ANI PHARMACEUTICALS INC Director's Dealing 2019

Apr 9, 2019

31676_dirs_2019-04-09_3beea7f1-8077-4a6d-9d08-b262df33bd9a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2019-04-06

Reporting Person: Marken James G. (SVP Ops & Prod Dev)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-04-06	Common Stock	F	337	$70.50	Disposed	75313	Direct
2019-04-07	Common Stock	F	144	$70.50	Disposed	75169	Direct

Footnotes

F1: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,100 shares of restricted stock, which was previously reported.

F2: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 469 shares of restricted stock, which was previously reported.